Search bioRxiv⌕ Search

Biology subjects

Atreya, M. R.

Publications and source records attributed to Atreya, M. R..

2 recordsLinked to original sources

Mortality Risk-Stratified Septic Serum Depresses Contractility and Mitochondrial Function in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

BackgroundSepsis-associated myocardial dysfunction (SAMD) is common in children with septic shock, is independently associated with mortality, and has no disease-modifying treatments. Differences in murine cardiomyocyte biology and repeated failures to translate discoveries into novel therapies for septic shock underscore a key translational need for human-relevant disease modeling. We sought to investigate human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) exposed to mortality risk-stratified septic serum as a model of SAMD. MethodsSerum from children with septic shock (n=120) was stratified by Pediatric Sepsis Biomarker Risk Model (PERSEVERE) II mortality probability as low, intermediate, or high risk. We conducted aptamer-based proteomic analysis of septic serum to determine differentially expressed proteins in children with high compared to low mortality risk. We treated iPSC-CMs with risk-stratified septic serum and defined contractile and mitochondrial functional and transcriptomic responses. ResultsWe found 612 differentially expressed proteins in children with high mortality probability, most prominently interleukins (IL)-6 and -8. High-risk septic serum reversibly depressed iPSC-CM contractility as measured by percent shortening, while low-risk septic serum had no impact. Further, high-risk septic serum depressed basal mitochondrial respiration, maximum uncoupled respiration, and coupled oxidative phosphorylation in iPSC-CMs relative to low-risk serum. We identified distinct patterns of gene expression due to risk-stratified serum with 5,293 differentially expressed genes, including upregulation of acute phase reactants and apolipoproteins and downregulation of chemokines, as well as transcriptional changes reflective of chronic IL-6 and IL-8 signaling. ConclusionsSeptic serum from children with high mortality risk exhibited distinct proteomic signatures, notably enriched for IL-6 and IL-8. Human iPSC-CMs differentially responded to risk-stratified septic serum, recapitulating phenotypic features of SAMD including reversible contractility depression and mitochondrial dysfunction with high-risk septic serum. These findings establish mortality risk-stratified septic serum exposure of iPSC-CMs as a human-relevant translational platform to interrogate mechanisms of myocardial dysfunction in septic shock.

immunology↗

International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium

Progress in the management of critical care syndromes such as sepsis, Acute Respiratory Distress Syndrome (ARDS), and trauma has slowed over the last two decades, limited by the inherent heterogeneity within syndromic illnesses. Numerous immune endotypes have been proposed in sepsis and critical care, however the overlap of the endotypes is unclear, limiting clinical translation. The SUBSPACE consortium is an international consortium that aims to advance precision medicine through the sharing of transcriptomic data. By evaluating the overlap of existing immune endotypes in sepsis across over 6,000 samples, we developed cell-type specific signatures to quantify dysregulation in these immune compartments. Myeloid and lymphoid dysregulation were associated with disease severity and mortality across all cohorts. This dysregulation was not only observed in sepsis but also in ARDS, trauma, and burn patients, indicating a conserved mechanism across various critical illness syndromes. Moreover, analysis of randomized controlled trial data revealed that myeloid and lymphoid dysregulation is linked to differential mortality in patients treated with anakinra or corticosteroids, underscoring its prognostic and therapeutic significance. In conclusion, this novel immunology-based framework for quantifying cellular compartment dysregulation offers a valuable tool for prognosis and therapeutic decision-making in critical illness.

immunology↗